Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Gordon

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Molecular Ecology|June 1, 1995
Species identification of Cecidophyopsis mites (Acari: Eriophyidae) from different Ribes species and countries using molecular geneticsB Fenton, G Malloch, A T Jones, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver diseaseS C Gordon, F M Hamzeh, P J Pockros, et al.
Gastroenterology|October 31, 2000
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy GroupJ G McHutchison, T Poynard, S Pianko, et al.
The American Journal of Gastroenterology|September 1, 1994
Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitisS C Gordon, V P Kodali, A L Silverman, et al.
Gastroenterology|June 1, 1995
Antibodies to carbonic anhydrase in patients with immune cholangiopathiesS C Gordon, T M Quattrociocchi-Longe, B A Khan, et al.
Journal of Hepatology|January 1, 1986
The spectrum of liver disease in the acquired immunodeficiency syndromeS C Gordon, K R Reddy, E E Gould, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USAJ Chhatwal, Q Chen, T Ayer, et al.
Journal of Viral Hepatitis|November 27, 2010
Hepatitis C treatment among racial and ethnic groups in the IDEAL trialA J Muir, K-Q Hu, S C Gordon, et al.
Journal of Viral Hepatitis|November 13, 2001
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapyJ G McHutchison, J A Shad, S C Gordon, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2014
The impact of hepatitis C burden: an evidence-based approachZ M Younossi, F Kanwal, S Saab, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Molecular Ecology|June 1, 1995
Species identification of Cecidophyopsis mites (Acari: Eriophyidae) from different Ribes species and countries using molecular geneticsB Fenton, G Malloch, A T Jones, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver diseaseS C Gordon, F M Hamzeh, P J Pockros, et al.
Gastroenterology|October 31, 2000
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy GroupJ G McHutchison, T Poynard, S Pianko, et al.
The American Journal of Gastroenterology|September 1, 1994
Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitisS C Gordon, V P Kodali, A L Silverman, et al.
Gastroenterology|June 1, 1995
Antibodies to carbonic anhydrase in patients with immune cholangiopathiesS C Gordon, T M Quattrociocchi-Longe, B A Khan, et al.
Journal of Hepatology|January 1, 1986
The spectrum of liver disease in the acquired immunodeficiency syndromeS C Gordon, K R Reddy, E E Gould, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USAJ Chhatwal, Q Chen, T Ayer, et al.
Journal of Viral Hepatitis|November 27, 2010
Hepatitis C treatment among racial and ethnic groups in the IDEAL trialA J Muir, K-Q Hu, S C Gordon, et al.
Journal of Viral Hepatitis|November 13, 2001
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapyJ G McHutchison, J A Shad, S C Gordon, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2014
The impact of hepatitis C burden: an evidence-based approachZ M Younossi, F Kanwal, S Saab, et al.
Pageof 10